Candriam S.C.A. - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,712,000
-4.0%
362,319
-0.0%
0.01%0.0%
Q4 2020$1,783,000
-68.3%
362,346
+54.9%
0.01%
-73.6%
Q3 2020$5,627,000
+10.9%
233,850
+78.8%
0.05%
-1.9%
Q2 2020$5,073,000130,7890.05%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 2,212,654$85,807,00018.79%
Versant Venture Management, LLC 1,854,229$71,907,001,00010.33%
SECTORAL ASSET MANAGEMENT INC 915,681$35,510,0003.26%
Consonance Capital Management LP 1,252,185$48,560,0002.91%
Redmile Group, LLC 2,268,718$87,981,0001.62%
SPHERA FUNDS MANAGEMENT LTD. 158,289$6,138,0000.58%
Rock Springs Capital Management LP 518,290$20,099,0000.55%
Parkman Healthcare Partners LLC 40,036$1,553,0000.44%
Virtus ETF Advisers LLC 11,435$443,0000.21%
KENNEDY CAPITAL MANAGEMENT LLC 131,414$5,096,0000.15%
View complete list of APREA THERAPEUTICS INC shareholders